Related Experiment Videos
Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
Ali Fazel1, Affan Quadri, Marc F Catalano
1Biliary Center, St. Lukes Hospital, Milwaukee, Wisconsin 53215, USA.
Gastrointestinal Endoscopy
|March 4, 2003
Summary
Pancreatic duct stent placement after ERCP significantly reduces the incidence of post-ERCP pancreatitis in high-risk patients. This intervention also appears to lessen the severity of pancreatitis when it does occur.
Area of Science:
- Gastroenterology
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Pancreatic Diseases
Background:
- Post-ERCP pancreatitis is a frequent complication.
- Papillary injury during ERCP can lead to pancreatic duct obstruction and pancreatitis.
- A study evaluated pancreatic duct stenting to prevent post-ERCP pancreatitis.
Purpose of the Study:
- To assess the efficacy of pancreatic duct stent placement in reducing post-ERCP pancreatitis frequency and severity.
- To investigate a preventive measure for a common ERCP complication.
Main Methods:
- A randomized prospective study included high-risk patients undergoing ERCP.
- Patients were randomized to receive a pancreatic duct stent or no stent post-procedure.
- High-risk criteria included difficult cannulation, sphincter of Oddi manometry, and/or endoscopic sphincterotomy.
Main Results:
- Pancreatic duct stenting reduced post-ERCP pancreatitis from 28% to 5% (p < 0.05).
- Pancreatitis severity tended to be lower in patients with pancreatic duct drainage.
Conclusions:
- Pancreatic duct stent insertion after ERCP is effective in preventing post-ERCP pancreatitis in high-risk individuals.
- Stenting is a valuable strategy for mitigating a significant complication of ERCP.